These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9049460)

  • 1. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist.
    Grabe DW; Low CL; Bailie GR; Eisele G
    Clin Nephrol; 1997 Feb; 47(2):117-21. PubMed ID: 9049460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of clinical pharmacist interventions in a hemodialysis unit.
    Tang I; Vrahnos D; Hatoum H; Lau A
    Clin Ther; 1993; 15(2):459-64; discussion 432. PubMed ID: 8519051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a pharmacist medication review clinic for haemodialysis patients.
    Mirkov S
    N Z Med J; 2009 Jun; 122(1297):25-37. PubMed ID: 19648999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a fax document for transfer of medication information to family physicians and community pharmacists caring for hemodialysis outpatients.
    Riley KD; Wazny LD
    CANNT J; 2006; 16(1):24-8. PubMed ID: 16615703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis.
    Manley HJ; Cannella CA; Bailie GR; St Peter WL
    Am J Kidney Dis; 2005 Oct; 46(4):669-80. PubMed ID: 16183422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting.
    Gómez MA; Villafaina A; Hernández J; Salgado RM; González MA; Rodríguez J; Martínez de la Concha M; Tarriño A; Gervasini G; Carrillo JA
    Ann Pharmacother; 2009 Feb; 43(2):339-46. PubMed ID: 19193590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment for chronic kidney disease service in high-risk patients at community health clinics.
    Patel HR; Pruchnicki MC; Hall LE
    Ann Pharmacother; 2005 Jan; 39(1):22-7. PubMed ID: 15546945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of medication-related problems among patients with renal compromise in an Indian hospital.
    Castelino RL; Sathvik BS; Parthasarathi G; Gurudev KC; Shetty MS; Narahari MG
    J Clin Pharm Ther; 2011 Aug; 36(4):481-7. PubMed ID: 21535060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.
    Wang HY; Chan AL; Chen MT; Liao CH; Tian YF
    Transplant Proc; 2008 Sep; 40(7):2319-23. PubMed ID: 18790223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-related problems on hospital admission: relationship to medication information transfer.
    Ong SW; Fernandes OA; Cesta A; Bajcar JM
    Ann Pharmacother; 2006 Mar; 40(3):408-13. PubMed ID: 16492794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic.
    Phillips SL; Carr-Lopez SM
    Am J Hosp Pharm; 1990 May; 47(5):1075-9. PubMed ID: 2337097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of pharmaceutical care in acute medical cardiovascular patients.
    Chisholm MA; Pittman DG; Longley JM; Mullis SR
    Hosp Pharm; 1995 Jul; 30(7):572-4, 577-8. PubMed ID: 10144212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.